Table 4.
Serum lipids before and after treatment
Treatment Group | P-value from pairwise comparison after treatment | ||||||
---|---|---|---|---|---|---|---|
Variable | DASH-WM | DASH-A | UC | DASH-WM vs. DASH-A | DASH-WM vs. UC | DASH-A vs UC | |
Total Cholesterol (mg/dl) | Before | 209 (198, 220) | 199 (188, 211) | 206 (195, 217) | |||
After | 184 (177, 199) | 199 (192, 205) | 205 (199, 211) | .008 | < .001 | .364 | |
Low Density Lipoprotein-Cholesterol (mg/dl) | Before | 128 (118, 138) | 122 (112, 132) | 126 (116, 136) | |||
After | 112 (106, 117) | 122 (116, 127) | 125 (119, 130) | .054 | .005 | .715 | |
High Density Lipoprotein-Cholesterol (mg/dl) | Before | 55 (50, 59) | 53 (49, 57) | 55 (51, 59) | |||
After | 54 (52, 55) | 51 (50, 53) | 54 (53, 56) | .115 | .911 | .047 | |
Triglycerides (mg/dl) | Before | 133 (116, 149) | 122 (106, 139) | 122 (106, 139) | |||
After | 93 (81, 106) | 129 (117, 142) | 130 (118, 142) | < .001 | < .001 | .900 |
Values are mean and 95% confidence interval. Values after treatment are adjusted for pretreatment levels of outcome variable, age, gender, and ethnicity. P-values are adjusted using Tukey’s Honestly Significant Difference procedure.